Mechanisms of Genomic Instability in Breast Cancer.
DNA damage repair
aneuploidy
breast cancer
chromosome instability
genomic instability
Journal
Trends in molecular medicine
ISSN: 1471-499X
Titre abrégé: Trends Mol Med
Pays: England
ID NLM: 100966035
Informations de publication
Date de publication:
07 2019
07 2019
Historique:
received:
05
02
2019
revised:
29
03
2019
accepted:
04
04
2019
pubmed:
13
5
2019
medline:
1
7
2020
entrez:
13
5
2019
Statut:
ppublish
Résumé
Breast cancer is the most common cancer among women globally. Genomic instability (GI) refers to the increased tendency to accrue genomic alterations. It drives heterogeneity and is a hallmark of cancer. Genomic integrity is closely guarded by several mechanisms, including DNA damage checkpoints, the DNA repair machinery, and the mitotic checkpoint. Alterations in these surveillance mechanisms cause GI. In breast cancer, several pathways maintaining genomic integrity are distinctly altered, including some that have been successfully exploited for therapeutic targeting. In this review, we comprehensively discuss the recent advances on the mechanisms of GI in breast cancer, highlighting DNA repair defects and chromosome segregation errors during mitosis. We further review the clinical implications and therapeutic potential of targeting GI in the era of precision medicine.
Identifiants
pubmed: 31078431
pii: S1471-4914(19)30090-5
doi: 10.1016/j.molmed.2019.04.004
pii:
doi:
Substances chimiques
Biomarkers, Tumor
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
595-611Informations de copyright
Copyright © 2019 Elsevier Ltd. All rights reserved.